Evaluation of Advanced Reverse Transcription-PCR Assays and an Alternative PCR Target Region for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus

2004 Journal of Clinical Microbiology 108 citations

Abstract

ABSTRACT First-generation reverse transcription-PCR (RT-PCR) assays for severe acute respiratory syndrome-associated coronavirus (SARS-CoV) gave false-negative results in a considerable fraction of patients. In the present study, we evaluated two second-generation, replicase (R) gene-based, real-time RT-PCR test kits—the RealArt HPA coronavirus LC kit (Artus, Hamburg, Germany) and the LightCycler SARS-CoV quantification kit (Roche, Penzberg, Germany)—and a real-time RT-PCR assay for the nucleocapsid (N) gene. Detecting the N-gene RNA might be advantageous due to its high abundance in cells. The kits achieved sensitivities of 70.8% (Artus) and 67.1% (Roche) in 66 specimens from patients with confirmed SARS (samples primarily from the upper and lower respiratory tract and stool). The sensitivity of the N-gene assay was 74.2%. The differences in all of the sensitivities were not statistically significant ( P = 0.680 [analysis of variance]). Culture cells initially contained five times more N- than R-gene RNA, but the respective levels converged during 4 days of virus replication. In clinical samples the median concentrations of R- and N-gene RNA, respectively, were 1.2 × 10 6 and 2.8 × 10 6 copies/ml (sputum and endotracheal aspirates), 4.3 × 10 4 and 5.5 × 10 4 copies/ml (stool), and 5.5 × 10 2 and 5.2 × 10 2 copies/sample (throat swabs and saliva). Differences between the samples types were significant but not between the types of target RNA. All ( n = 12) samples from the lower respiratory tract tested positive in all tests. In conclusion, the novel assays are more sensitive than the first-generation tests, but they still do not allow a comprehensive ruling out of SARS. Methods for the routine sampling of sputum without infection risk are needed to improve SARS RT-PCR.

Keywords

VirologyReverse transcription polymerase chain reactionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BiologyBetacoronavirusCoronavirusCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakPolymerase chain reactionReal-time polymerase chain reactionReverse transcriptaseMedicineGeneGeneticsPathologyGene expressionOutbreakInfectious disease (medical specialty)Disease

Affiliated Institutions

Related Publications

Publication Info

Year
2004
Type
article
Volume
42
Issue
5
Pages
2043-2047
Citations
108
Access
Closed

External Links

Citation Metrics

108
OpenAlex

Cite This

Christian Drosten, Lily-Lily Chiu, Marcus Panning et al. (2004). Evaluation of Advanced Reverse Transcription-PCR Assays and an Alternative PCR Target Region for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus. Journal of Clinical Microbiology , 42 (5) , 2043-2047. https://doi.org/10.1128/jcm.42.5.2043-2047.2004

Identifiers

DOI
10.1128/jcm.42.5.2043-2047.2004